Treatment of Sarcoidosis in Hepatic Sarcoidosis with Jaundice, Cholestasis, and Pruritus
Hepatic involvement in sarcoidosis can produce significant cholestatic disease, manifesting as jaundice, impaired bile flow, and pruritus. This subset requires a targeted approach distinct from pulmonary or systemic sarcoidosis management.
Patients present with hepatic sarcoidosis complicated by jaundice, cholestasis, and pruritus — reflecting granulomatous infiltration of the liver and disrupted biliary physiology. These cholestatic features drive both symptom burden and the treatment rationale in this setting.
The protocol for this presentation centres on an oral bile acid agent directed at relieving cholestatic symptoms, including jaundice and itching. The full dosing schedule, titration guidance, and clinical monitoring framework are detailed in the complete structured regimen.
References
Ursodeoxycholic acid at 10 mg/kg/day may be used to manage symptoms of cholestasis, including jaundice and pruritus.
View source ↗